PLK1 inhibition by volasertib suppresses key transcriptional regulators underlying fibroblast activation and pulmonary fibrosis
- 1 February 2026
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 330 (2) , L132-L144
Abstract
Excessive proliferation, impaired apoptotic clearance, and extracellular matrix (ECM) production are pathological features of fibroblast activation that together result in scar tissue formation in pulmonary fibrosis. This study identifies the previously unrecognized role for the WT1-MYCN-PLK1 axis in promoting fibroblast activation and highlights the therapeutic potential of PLK1 inhibition with volasertib as an antifibrotic strategy.Keywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (1R01 HL134801)
- HHS | NIH | National Heart, Lung, and Blood Institute (1R01 HL157176)
This publication has 58 references indexed in Scilit:
- The Amot/integrin protein complex transmits mechanical forces required for vascular expansionCell Reports, 2021
- In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53Molecular Oncology, 2019
- MYCN-induced E2F5 promotes neuroblastoma cell proliferation through regulating cell cycle progressionBiochemical and Biophysical Research Communications, 2019
- Idiopathic pulmonary fibrosisNature Reviews Disease Primers, 2017
- Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell SurvivalMolecular Cell, 2016
- Mechanisms of Lung Fibrosis ResolutionThe American Journal of Pathology, 2016
- N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial CellsCancer Cell, 2016
- Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapyLeukemia, 2014
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- MYCN silencing induces differentiation and apoptosis in human neuroblastoma cellsBiochemical and Biophysical Research Communications, 2006